Shivakumar and colleagues recently published their randomized, controlled, non-inferiority trial comparing aspirin 81mg daily vs rivaroxaban 10mg daily for 5 days followed in both groups by aspirin 81mg daily for another 9 days (knee arthro

An interesting article in Time magazine highlights the economics that can contribute to fragile medicine supply chains.

With statements continuing to emerge in certain circles in the USA regarding safety of medications in pregnancy, a commentary in JAMA Psychiatry reminds us to take a step back and look at the whole picture.